Drugs / KP24 Medicated Foam
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00381082 | Sep → Nov 2004 | lice infestation | Uniquest Pty Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KP24 Medicated Foam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00381082 ↗ |
| Route | Topical | “KP24 and Banlice were applied twice separated by a one week interval.” NCT00381082 ↗ |